Whats New in the World of Psychology? These Press Releases, will keep you up to date on all things Psychology related.
Investments focus on expanding access to behavioral health care PORTLAND, Ore., Sept. 13, 2023 /PRNewswire/ — Cambia Health Foundation announced $300,000 in investments today to expand access to behavioral health care among adults aged 55 and older. This funding falls within the…
Organization brings over 75 years of healthcare revenue cycle experience, earns award for third straight year
DURHAM, N.C., Sept. 13, 2023 /PRNewswire-PRWeb/ — Revco Solutions, Inc. is proud to announce it was selected as one of the Best Places to Work in Collections for 2023 by the ACA International and Best Companies Group. This annual survey and award program was designed to identify, recognize, and honor the best places of employment in the collections industry.
This is the third year in a row that Revco Solutions was selected as a top company.
“Revco attracts the very best talent, and we appreciate our team’s tireless work effort, not only for our clients but for our Revco family, which enables accolades such as this,” shared Steve Gayheart, COO of Revco Solutions. Added Mark Schabel, CEO, “Our Revco staff embodies our motto of ‘serving one another so we can serve the world’ and being selected as a Best Company to Work in Collections supports our belief that serving others starts within our own four walls. We will continue to work tirelessly to be considered for this award each and every year and my deepest thank you to ACA International and Best Companies Group for showcasing our team’s efforts for the past three years.”
The Best Companies Group’s process includes a rigorous two-part survey process. The first part consisted of evaluating each nominated company’s workplace policies, practices, philosophy, systems, and demographics. The second portion of the process was an employee survey designed to measure each employee experience. Typically, a randomly selected group of employees is asked to participate, however Revco Solutions made the investment to have all of their employees surveyed – over 450 nationwide. Revco Solutions is pleased that year-over-year, our employee satisfaction continues to increase. “We will continue to cultivate an environment that builds culture and ultimately our team’s happiness in the workplace,” added Schabel.
About Revco Solutions
Revco Solutions, Inc. brings over 75 years of healthcare revenue cycle experience, utilizing the latest omni-channel patient communications and innovative business intelligence tools. With solutions scalable to our clients’ unique needs, we provide an industry-leading secure, compliant, and patient-friendly framework, powered by our service-oriented staff. Revco Solutions manages billions in placements annually from hundreds of physician practices, hospitals, and health systems, including several of the country’s top ten largest non-profit systems. To learn more, visit www.RevcoSolutions.com.
Media Contact
Angela Stokes, Revco Solutions, Inc., 1 919-281-2836, [email protected], https://revcosolutions.com/
SOURCE Revco Solutions, Inc.
The featured speakers will review the current state of lentiviral vector engineering, recent breakthroughs and new ways to make high-titer stable producer cell lines.
A live Q&A session will follow the presentation, offering attendees a chance to pose questions to the expert team.
Register for the live webinar taking place on Monday, October 2, 2023, at 11am EDT (4pm BST/UK) featuring expert speakers from Oxford Biomedica, Nick Clarkson, Vice President, Head of Platform Research; and Dan Farley, Senior Director of the Vector Engineering Group.
For more information, or to register for this event, visit 4th Generation Lentiviral Vectors: An Improved Gene Delivery System.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Ayesha Rashid, Xtalks, +1 (416) 977-6555 x272, [email protected]
SOURCE Xtalks
Greenberg Traurig, LLP represented Huadong Medicine Co., a Chinese publicly traded pharmaceutical company, in negotiating two strategic licensing agreements to develop and commercialize market-leading medications in Greater China and Southeast Asia.
NEW YORK, Sept. 12, 2023 /PRNewswire-PRWeb/ — Greenberg Traurig, LLP represented Huadong Medicine Co., a Chinese publicly traded pharmaceutical company, in negotiating two strategic licensing agreements to develop and commercialize market-leading medications in Greater China and Southeast Asia.
Most recently, the firm advised Hangzhou Zhongmei Huadong Pharmaceutical, a subsidiary of Huadong Medicine, in negotiating a licensing agreement with MC2 Therapeutics to develop and market MC2’s Wynzora cream for treating plaque psoriasis in adults in Greater China.
Copenhagen-based MC2 will receive $16 million in upfront and regulatory milestone payments and is eligible to receive an additional approximately $36 million plus royalties if the Huadong unit achieves certain sales milestones. The licensing agreement covers the territory of mainland China, Hong Kong, Macau, and Taiwan.
In late June, Greenberg Traurig attorneys advised Huadong in negotiating a licensing agreement with Arcutis Biotherapeutic for the development, manufacture, and commercialization of topical roflumilast in Greater China and Southeast Asia. Topical roflumilast is used for multiple dermatological conditions including plaque psoriasis, seborrheic dermatitis, atopic dermatitis, and potentially additional dermatological conditions in the future.
The region covered by the licensing agreement includes mainland China, Hong Kong, Macau, Taiwan, Indonesia, Singapore, The Philippines, Thailand, Myanmar, Brunei, Cambodia, Laos, Malaysia, and Vietnam. In a release issued Arcutis, the company will receive an upfront payment of $30 million, and an additional $64.25 million if certain regulatory and sales milestones are achieved by Huadong Medicine. Arcutis is also eligible to receive tiered double-digit royalties.
The Greenberg Traurig team representing Huadong in both transactions was led by Atlanta Corporate Shareholder Wayne H. Elowe, co-chair of the firm’s global Life Sciences and Medical Technology Group and co-chair of the Corporate Practice in Atlanta, and Atlanta Corporate Associate William H. Grossenbacher III.
About Greenberg Traurig: Greenberg Traurig, LLP has more than 2650 attorneys in 47 locations in the United States, Europe and the Middle East, Latin America, and Asia. The firm is a 2022 BTI “Highly Recommended Law Firm” for superior client service and is consistently among the top firms on the Am Law Global 100 and NLJ 500. Greenberg Traurig is Mansfield Rule 5.0 Certified Plus by The Diversity Lab. The firm is recognized for powering its U.S. offices with 100% renewable energy as certified by the Center for Resource Solutions Green-e® Energy program and is a member of the U.S. EPA’s Green Power Partnership Program. The firm is known for its philanthropic giving, innovation, diversity, and pro bono. Web: http://www.gtlaw.com.
Media Contact
Bea Garcia, Greenberg Traurig, LLP, +1 305.579.7703, [email protected], https://www.gtlaw.com/
SOURCE Greenberg Traurig, LLP
Bola AI continues to revolutionize the dental field by introducing its cutting-edge AI to dental schools.
BOSTON, Sept. 12, 2023 /PRNewswire-PRWeb/ — Bola Technologies, Inc. (Bola AI), a leading provider of voice-AI technology for dental professionals, is pleased to announce that its cutting-edge solution will now be available to students as well through a new partnership with the University of Pittsburgh School of Dental Medicine.
The partnership will take Bola AI’s Voice Perio and Clinical Notes solutions into the classroom and allow students to familiarize themselves and train on the latest AI technology in preparation for entering the workforce and their own dental practices.
“AI solutions are already making a huge impact in dental offices today,” said Rushi Ganmukhi, founder and CEO of Bola AI. “It only makes sense that future professionals should become familiar with the technology that is currently transforming the overall dental experience. The more conversant students become with the advantages of AI in their training programs, the easier they will adapt to it in a professional setting.”
The school has been piloting the Bola AI solution in its hygiene clinic for a few months, with further incorporation of the technology expected throughout the fall. First impressions have been positive from students and faculty alike, who have noted enhanced clinical efficiency, standardized workflow for periodontal charting and improved adherence to infection control protocols.
“I think partnering with Bola AI may have a tangible impact on improving clinical efficiency for our dental students, dental hygiene students and residents,” said Sarah E. Grafton, DMD, assistant dean for clinical efficiency and analytics at the University of Pittsburgh School of Dental Medicine. “There is nothing more valuable than time, and our time to educate our students chairside is limited. Utilizing technology, specifically artificial intelligence, to improve the experience for both the student and the patient is a great opportunity with limitless possibilities.”
AI and deep learning have made incredible strides in recent years, with computer vision, language processing and speech recognition achieving near-human levels. Bola AI’s Voice Perio solution empowers dental staff to seamlessly enter periodontal data directly into client PMs and EHR systems in real time while delivering speech accuracy of 99% and allowing for variable accents and flexible phrasing. Additionally, Clinical Notes provides a fast, accurate voice transcription, freeing up dentists, hygienists and front-office staff to better serve the needs of patients.
Students are typically quick and enthusiastic adapters to new technology, especially when that technology can save them a significant amount of time. Periodontal charting is a tedious but very necessary component of a patient exam, and the new AI technology allows more time to focus on the evaluation of the charting rather than documentation.
Bola AI hopes to be able to reach similar partnerships with additional dental schools. “Our goal is to team up with additional universities so that we will better grow and prepare dental students for years to come,” Ganmukhi said.
About Bola AI
Bola AI is the leader in voice-AI software for the dental practice. By harnessing the power of advanced technologies, this platform can provide efficient, fully integrated and accurate speech (99%) solutions for periodontal charting, clinical notes and more. With Bola AI, practices can empower themselves to create a smarter patient experience while improving operational efficiency and driving revenue. Headquartered in Boston, MA, Bola AI partners with Dentrix and Dentrix Ascend, Curve, Patterson and more. For more information, visit bola.ai.
About the University of Pittsburgh School of Dental Medicine
Pitt Dental Medicine was founded in 1896 and adheres to its mission of improving oral health through teaching, research and service. The school runs several dental clinics and 11 specialty clinics while training its students to care for patients skillfully, professionally and compassionately.
Pull Quote
The more conversant students become with the advantages of AI in their training programs, the easier they will adapt to it in a professional setting.
Media Contact
Jake Goeckeritz, Bola AI, (801) 830-6317, [email protected], https://bola.ai/
SOURCE Bola AI
“Consumers around the globe are looking for new opportunities to elevate their immune health to ensure that they can power through their days feeling their best,” said Karen Todd, MBA, RD, Vice President of Global Brand Marketing, Kyowa Hakko USA, Inc. “We’re so excited to have partnered with the Quifaest team to give consumers throughout Mexico a novel option with our first launch in this market.”
IMMUSE™ is Kyowa’s postbiotic that delivers a breakthrough approach to more comprehensive immune support. Over 30 published clinical studies, including 15 human trials, support IMMUSE™ as an immune activator. This means that the ingredient proactively supports the immune system through a novel method of action that activates pDC (plasmacytoid dendritic cells)*.
The pDC, a rare type of immune cell, functions as a key leader of the immune system and has been shown to activate pivotal cells, such as NK, Killer-T, Helper-T, and B cells, for a more comprehensive approach to immune support*.
Founded in 2002, Quifaest is committed to manufacturing food supplements and pharmaceutical-grade herbal medicines and remedies that feature state-of-the-art ingredients, all to bring excellence in nutrition to Mexico.
“I am so glad to announce that IMMUSE™ is now available in Mexico,” Quifaest Group CEO Marciano Mateos said. “Our corporate mission has found a perfect match with Kyowa. This is a great partnership that will promote dietary supplements that are manufactured with very high-quality ingredients supported by science.”
The product will be sold at QuifaHealth stores in malls throughout the Mexico City area, and Quifaest is anticipating additional distribution. Please visit http://www.Dgreen.com.mx
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
About IMMUSE™
IMMUSE™ is a postbiotic that delivers a new, breakthrough approach to broad range immune support*. As a clinically researched immune activator* supported by 30 published studies, including 15 human trials, IMMUSE™ proactively supports the immune system through a novel method of action that activates pDC (plasmacytoid dendritic cells)*. The pDC, a rare type of immune cell, functions as a key leader of the immune system and has been shown to activate pivotal cells such as NK, Killer-T, Helper-T, and B cells, for a more comprehensive approach to immune support*. Its unique mechanism of action, discovered by Kyowa Hakko’s parent company Kirin Holdings Co., Ltd., is opening doors for discovering postbiotics concerning immune health.
About Kyowa Hakko USA:
Kyowa Hakko USA is the North & South American office of Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing pharmaceuticals, nutraceuticals, and food & beverage products. Kyowa is the maker of branded ingredients, including IMMUSE™ LC-Plasma, EYEMUSE™ Lacticaseibacillus paracasei KW3110, Cognizin® Citicoline, Pantesin® Pantethine, Setria® Glutathione, as well as L-Alanyl-L-Glutamine. For more information, visit http://www.kyowa-usa.com.
About Quifaest
Experts in the manufacturing of food supplements and pharmaceutical grade herbal medicines and remedies, Quifaest’s products are all developed by an innovative scientific and technical team that select state-of-the-art ingredients according to their needs. The company has the technical and scientific capacity to register, develop, manufacture, distribute, and market its products throughout the Mexican market.
Media Contact
Karen Todd, Kyowa Hakko USA, 7343553073, [email protected], www.immusehealth.com
SOURCE Kyowa Hakko USA
“We are very excited to bring Kevin onboard,” said Young. “He is a visionary with a success rate to back up his bold plans, as evidenced by his remarkable track record in growing annual recurring revenue, client numbers, and client satisfaction.”
McDonald has held executive positions in operations, client management, product strategy and business development at leading healthcare companies including HMS, Cotiviti and Discovery Health Partners. Most recently he served as Chief Growth Officer for two venture capital backed startups bringing innovative solutions to healthcare payers.
McDonald received a BA and an MBA from Union College in Schenectady, NY, and has been a featured speaker at several healthcare conferences.
About MedReview
Headquartered in the financial district of New York City and serving all U.S. states and territories, MedReview has been a leading provider of payment integrity, utilization management, and quality surveillance services for more than 40 years. A physician-led organization with a passion for ensuring that health care claims fairly represent the care provided, MedReview provides timely independent hospital billing audits and DRG clinical validation reviews on behalf of health plans, government agencies, and Taft-Hartley organizations, saving millions of dollars for its clients each year. For more information, please visit http://www.medreview.us.
Media Contact
Tracey Osentoski, MedReview, Inc., 248-977-0940, [email protected], www.medreview.us
SOURCE MedReview, Inc.
Rod Mollere, D.D.S., P.A. of El Paso, Texas, is now El Paso Family Dental and is serving patients of all ages and backgrounds. The successful and well-known dental practice has undergone several exciting changes, including an acquisition, a new website, and welcoming a new dentist.
EL PASO, Texas, Sept. 12, 2023 /PRNewswire-PRWeb/ — Rod Mollere, D.D.S., P.A. of El Paso, Texas, has rebranded as El Paso Family Dental and is serving patients of all ages and backgrounds. The successful and well-known dental practice has undergone several exciting changes, including introducing a new website (https://www.elpasofamilydentalcare.com) and welcoming a new dentist.
El Paso Family Dental is proud to announce general dentist Dr. Alessandro Retis as the new lead dentist in the practice. Prior to moving to Texas, Dr. Retis completed a one-year oral & maxillofacial surgery residency at the LAC+USC Medical Center, Level 1 trauma center for downtown Los Angeles. During his residency, he was responsible for taking primary call for maxillofacial trauma and for teaching USC dental students dentoalveolar surgery and wisdom teeth extractions. His experience here will benefit all patients at El Paso Family Dental.
Dr. Retis is a 2019 UNLV School of Dental Medicine graduate and worked as a general dentist in Kingsville, Texas, prior to joining the practice. He and the El Paso Family Dental team are highly qualified and experienced in all areas of family dentistry. They welcome patients of all ages, providing individualized care that Texas and New Mexico dental patients expect and deserve.
In addition to welcoming Dr. Retis, El Paso Family Dental now has a new website at https://www.elpasofamilydentalcare.com. Their dental providers offer the following services to families from Northwest El Paso, Northeast El Paso, Logan Heights, Sunland Park, Prado Verde, Santa Teresa, Fort Bliss, East El Paso, Mission Valley, El Paso County, and all surrounding areas, including Chaparral, Mesquite Hills and Las Cruces, New Mexico:
“I am excited to provide quality dental care to individuals and families throughout the El Paso area. My team and I look forward to building relationships with those who entrust their care to us and helping them meet their dental health and cosmetic goals. Whether it’s a routine exam and cleaning, teeth whitening, or a dental emergency, you can count on us to be there for you,” says Dr. Alessandro Retis.
At El Paso Family Dental, patients are like family. Their staff greets every dental patient with a warm smile and a welcoming atmosphere at each visit. Dr. Retis and his team of dental professionals help patients of all ages feel relaxed and comfortable during their visit, no matter what they are there for.
Equipped with the latest technology, El Paso Family Dental provides advanced care to improve your dental health and enhance your overall experience.
About El Paso Family Dental
El Paso Family Dental is a general dentistry family practice located at 965 N Resler Dr, Suite 105, El Paso, TX 79912. They are available by phone at 915-585-2020 or online at https://www.elpasofamilydentalcare.com. Their office accepts many different types of dental insurance, including Texas and New Mexico Medicaid.
Media Contact
Robert Messinger, Dentalfone, 203.979.4013, [email protected]
SOURCE El Paso Family Dental
Dr. Levine attended the New York University School of Medicine, served as the President of the NYU Alumni Association, and was the only physician on NYU’s Board of Trustees during his 7-year tenure. Recently he was awarded the Meritorious Service Award, the highest award bestowed upon an alumnus for their extraordinary service and continuing devotion to NYU and who embodies the University motto: To Persevere and to Excel.
Dr. Levine completed his residency in Obstetrics and Gynecology at New York-Presbyterian Hospital – Columbia University Medical Center and then completed his fellowship in reproductive endocrinology and infertility at New York-Presbyterian Hospital – Weill Cornell Medical College.
In 2015 he was awarded the highest prize by the American Society of Reproductive Medicine for his assisted reproductive technology submission on 3D sperm imaging techniques and frequently consults on new and disruptive fertility-related technologies.
In 2017, Dr. Levine was honored with the Doctors of Distinction award in Westchester County, was also named a Rising Star by Super Doctors in 2017 and 2018, a New York Super Doctor in 2019 & 2020, and a Castle and Connolly “Top Doctor” in 2019 & 2020.
Dr. Levine resides in Manhattan with his wife Alexis and daughter Izabel. In his off time, he is a fervent daily reader and enjoys running in Central Park.
About CCRM Fertility
CCRM Fertility is a global pioneer in fertility science, research, and treatment, offering access to a network of award-winning fertility doctors, a full suite of fertility services, innovative technologies, and cutting-edge labs. CCRM proudly operates 11 state-of-the-art IVF labs and 25 fertility clinics across the U.S. and Canada, including Atlanta, Boston, Dallas, Denver, Houston, New York, Northern Virginia/D.C., Minneapolis, Orange County, San Francisco Bay Area, and Toronto. CCRM specializes in the most advanced fertility treatments, with deep expertise in vitro fertilization (IVF), fertility assessment, fertility preservation, LGBTQ family building, genetic testing, third-party reproduction, and egg donation.
Learn more about Dr. Brian A. Levine. by visiting: https://hauteliving.com/hautebeauty/mdmember/dr-brian-a-levine/
ABOUT HAUTE MD NETWORK:
Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in health and wellness, providing readers with expert advice on aesthetic and medical treatments through its network of acclaimed doctors and beauty experts.
For more about Haute MD, visit https://hauteliving.com/hautebeauty/mdmember/
Media Contact
Brooke Klaiman, Haute Beauty by Haute Living, 5612122126, [email protected], https://hauteliving.com/hautebeauty/mdmember/
SOURCE Haute Beauty by Haute Living
Late-breaking oral presentation on the positive primary outcomes of aderamastat, a first-in-class, oral MMP-12 inhibitor in a Phase 2 Phase 2 proof-of-concept allergic asthma study, supporting potential novel anti-inflammatory mechanism for respiratory diseases. TAIPEI, Sept. 12, 2023…
